Support our Foundation of Myology project
Following on from previous work on facioscapulohumeral muscular dystrophy (FSHD), researchers in Marseilles have studied the characteristics of facial muscle deficit in people with inclusion myositis (IBM), an inflammatory pathology…
Monitoring, either as part of the usual follow-up of patients with muscular dystrophy or as part of clinical trials, is largely based on the use of functional scores: researchers report,…
An international study published in December 2022 analysed the pregnancy and childbirth experiences of women with neuromuscular diseases, collected via online questionnaires: 721 pregnancies were reported by 305 women; 26…
A selective inhibitor of p38 α and β MAP kinases, losmapimod has been investigated in a phase II trial called ReDUX4, randomized, double-blind, placebo-controlled, lasting 48 weeks in 80 adults…
Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN. Thursday 27 mai 2021 – 4:00 am (Paris time) What’s new in FSHD ? Prof. Sabrina Sacconi…